NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

數位化療法 (DTx)的全球市場 - 產業分析與預測:2021年∼2027年

Global Digital Therapeutics Market By End Use, By Applications, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

出版商 KBV Research 商品編碼 1004819
出版日期 內容資訊 英文 192 Pages
訂單完成後即時交付
價格
數位化療法 (DTx)的全球市場 - 產業分析與預測:2021年∼2027年 Global Digital Therapeutics Market By End Use, By Applications, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027
出版日期: 2021年04月30日內容資訊: 英文 192 Pages
簡介

全球數位化療法 (DTx)的市場規模,預計至2027年達到145億美元,在預測期間內以21.8%的年複合成長率成長。智慧型手機和平板電腦,醫療用應用程式的採用劇增,慢性疾病增加,醫療費管理的必要性高漲,也提高全球數位化療法 (DTx)的需求。

本報告提供全球數位化療法 (DTx) 市場相關調查分析,市場概要,各市場區隔的市場分析,各地區的市場分析,主要企業等相關的系統性資訊。

目錄

第1章 市場範圍與調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 競爭分析:世界

  • KBV Cardinal Matrix
  • 最近的產業的策略性發展
  • 主要成功策略

第4章 全球數位化療法 (DTx) 市場:各最終用途

  • 患者
  • 醫療提供者
  • 保險者
  • 僱用主人
  • 其他

第5章 全球數位化療法 (DTx) 市場:各應用領域

  • 糖尿病
  • CNS疾病
  • 呼吸疾病
  • 戒煙
  • 肥胖
  • CVD
  • 其他

第6章 全球數位化療法 (DTx) 市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第7章 企業簡介

  • ResMed, Inc.(Propeller Health)
  • Teladoc Health, Inc.(Livongo Health)
  • Noom, Inc.
  • Omada Health, Inc.
  • Welldoc, Inc.
  • Canary Health
  • Mango Health, Inc.(TrialCard, Incorporated)
  • 2Morrow, Inc.
  • Pear Therapeutics, Inc.
  • Mindstrong, Inc.
目錄

The Global Digital Therapeutics Market size is expected to reach $14.5 billion by 2027, rising at a market growth of 21.8% CAGR during the forecast period. Digital therapeutics is a group of applications, which assist in curing diseases by altering patient's behaviour and offering remote supervision to enhance long-term health results. There is a broad range of products include in digital therapeutics like wearable devices, mobile applications, and sensors. However, it is different from digital health based on the clinical results for patients.

Consumer health-oriented technologies like calorie-counter and step counter do not fall under the ambit of digital therapeutics. Digital therapeutics is a new category of healthcare solutions that utilizes digital technology to protect, manage and cure different medical conditions. Additionally, it also uses digital health technologies to cure a patient with some medical problems, which is why it is becoming a popular concept in today's digital world.

There is an increasing demand for digital therapeutics across the globe, due to the rising adoption of smartphones & tablets along with healthcare apps, increasing cases of chronic diseases, and the growing need to manage healthcare costs. Moreover, high growth opportunities in the undiscovered markets are anticipated to offer new growth avenues for the manufacturers operating in the digital therapeutics market. Though, the absence of awareness related to digital therapeutics in emerging nations and the increasing concern about patient data is hampering the growth of the market.

End Use Outlook

Based on End Use, the market is segmented into Patients, Providers, Payers, Employers and Others. The providers market segment is estimated to record a significant growth due to the determinants like increasing number of companies are using digital therapeutics to provide clinically proven therapies without a healthcare setup, and also offer reliable patient engagement. This segment has huge potential for growth and players are also gaining more interest in covering digital therapeutics.

Application Outlook

Based on Applications, the market is segmented into Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others. On the basis of application, the diabetes market segment procured the highest share in the total revenue of the market in 2020. This segment is estimated to witness the highest growth over the forecast period. The increasing cases of diabetes among the people across the globe are contributing to the growth of the segment.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. By region, North America emerged as a leading region in the digital therapeutics market with the highest market share in 2020. It is due to the factors like the prevalence of key market players, full developed healthcare infrastructure, increasing government initiatives, and growing prevalence of chronic diseases.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; ResMed, Inc. is the major forerunner in the Digital Therapeutics Market. Companies such as Pear Therapeutics, Inc., Omada Health, Inc., and Noom, Inc., Mindstrong, Inc., Welldoc, Inc. are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ResMed, Inc. (Propeller Health), Teladoc Health, Inc. (Livongo Health), Noom, Inc., Omada Health, Inc., Welldoc, Inc., Canary Health, Mango Health, Inc. (TrialCard, Incorporated), 2Morrow, Inc., Pear Therapeutics, Inc., and Mindstrong, Inc.

Recent strategies deployed in Digital Therapeutics Market

Partnerships, Collaborations, and Agreements:

Mar-2021: Welldoc joined hands with Eli Lilly, an American pharmaceutical company. This collaboration aims to make the latest version of Welldoc's BlueStar, an app-based diabetes management platform, which would combine insulin dosing data for Lilly insulin products.

Jan-2021: Pear Therapeutics signed an agreement with etectRx, a Digital Health company. This agreement aims to develop a product, which integrates the former's digital therapeutics with a digital pill portfolio. Under this agreement, the companies will meet quarterly to discuss potential collaborations with the pharma industry.

Aug-2020: Teladoc Health came into partnership with NTCA, the Rural Broadband Association. Under this partnership, both entities aim to bring behavioral health services to more than 40,000 people, who are enrolled in NTCA's Group Health Program (GHP) medical plan.

May-2020: Noom collaborated with LifeScan, a world leader in blood glucose monitoring. Under this collaboration, the companies work on a pilot program combining the latter company's OneTouch Reveal app with Noom's digital diabetes & weight loss management program.

Mar-2020: Welldoc collaborated with Dexcom, the global leader in continuous glucose monitoring (CGM) systems for people with diabetes. Under this collaboration, Welldoc's award-winning BlueStar, a digital health product for people having type 1 and type 2 diabetes, is allowed to provide insights to Dexcom G6 CGM system customers.

Feb-2020: Welldoc partnered with Redox, the leading interoperability platform for healthcare data exchange. This partnership would enable providers to get and review insights about customers of the BlueStar digital health app for diabetes management personal: y in their EHR at the point of care.

Jan-2020: Noom teamed up with EVERSANA, the leading independent provider of commercial services to the life science industry. This collaboration aims to grow medication adherence and enhance health outcomes for the many patients who are suffering from chronic and rare diseases across the world.

Jan-2020: Pear Therapeutics came into an agreement with Apricity Health, a powerful digital platform that helps clinical teams optimally monitor and manage cancer treatment. This agreement aims to make up to two product candidates for precision management of patients, who are undergoing cancer treatment.

Nov-2019: Welldoc came into collaboration and license agreement with Astellas Pharma. Together, the companies make and commercialize BlueStar in Japan and other Asian markets for patients having diabetes and increase the adoption of BlueStar in the U.S. market.

Oct-2019: Noom joined hands with Novo Nordisk, a Danish multinational pharmaceutical company. The collaboration aimed to implement digital therapies for obesity.

Oct-2019: Omada Health partnered with Abbott, an American multinational medical devices and health care company. Together, the companies aimed to integrate Abbott's revolutionary FreeStyle Libre system, a CGM technology, with Omada Health's pioneering digital care program, to make the latest paradigm for individuals with Type 2 diabetes.

Oct-2019: Welldoc formed a partnership with Competitive Health, which develops and delivers technology-driven consultative solutions. In this partnership, Competitive Health's customer would be provided BlueStar, which is Welldoc's digital assistant for people having type 2 diabetes. Competitive Health also introduced the SHOWBenefits platform to its enrolled employers to simplify the delivery of healthcare by combining all medical & healthcare services on a single mobile platform.

Oct-2019: Pear Therapeutics came into collaboration with Ironwood Pharmaceuticals, a pharmaceutical company. This collaboration aimed to evaluate Prescription Digital Therapeutics (PDTs) for curing selected indications under the gastrointestinal (GI) space. The collaboration also leverages Pear's platform and offering in PDTs with Ironwood's advanced GI franchise expertise.

Jun-2019: Canary Health formed a partnership with Catasys, a leading AI and technology-enabled healthcare company. Under this partnership, Catasys has developed a distinct, proprietary approach to active health plan members with their behavioral health requirements, who are also having chronic diseases. Providing digital access to Canary Health's online program to these members and expand its platform to address chronic disease personally.

Mar-2019: Mango Health came into partnership with EnvoyHealth, the pharma services division of Diplomat. Through this partnership, Mango Health would develop a custom white-label version of its app that Envoy would provide to patients to support its traditional hub services.

Feb-2019: Propeller Health partnered with Orion Corporation, a Finnish pharmaceutical company. Under this partnership, Orion's prevailing line of Easyhaler products would link to Propeller's digital medicine platform through a small, custom-built sensor. Through connecting Easyhaler to Propeller's digital platform, patients and their providers got a new ability to enhance the customer experience of Easyhaler products and assist patients to more adhere to the treatments.

Acquisition and Mergers:

Jul-2020: Teladoc Health acquired InTouch Health, a virtual care platform providing healthcare solutions. Through this acquisition, Teladoc broadened its offerings to InTouch Health's customer base of more than 450 hospitals. In addition, Teladoc integrated InTouch's technologies, customized for complex medical environments of every shape and size, to assist Teladoc to provide a broader range of services and enhanced patient experience in ambulatory care, acute care, and home care settings.

May-2020: Omada Health took over Physera Health, a company that offers telehealth physical therapy appointments. The acquisition added one more digital health platform to Omada's toolbox that consists of solutions for diabetes, hypertension, and behavioral health.

Jan-2020: Pear Therapeutics took over two technologies for pain treatment. This acquisition includes two clinical-stage digital therapeutics from Firsthand Technology. It includes utilizing virtual reality headsets to decrease both acute & chronic pain, which in early trials showcased substantial pain reduction in patients.

Product Launches and Product Expansions:

Apr-2021: Omada Health unveiled Omada Insights Lab. It is an initiative that focuses on using science to maximize the clinical efficacy and behavioral design of its digital therapeutics (DTx) products just like Omada Health provides DTx for various chronic conditions & preventative health.

May-2021: Pear Therapeutics introduced PEAR Assistance Program. This program aims to make sure about eligible patients with Substance Use Disorder or Opioid Use Disorder get access to FDA-authorized prescription digital therapeutics (PDTs) for addiction treatment. Under this program, the company offers access to reSET and reSET-0, free of cost, to eligible patients, who are under the monitoring of a licensed US healthcare provider.

Jun-2018: Omada Health launched new programs developed to support people with Type 2 diabetes & hypertension. The addition of diabetes and hypertension programs was a part of Omada's objective to become more comprehensive health management and coaching offering.

Scope of the Study

Market Segments covered in the Report:

By End Use

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

By Application

  • Diabetes
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Obesity
  • CVD
  • others

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • ResMed, Inc. (Propeller Health)
  • Teladoc Health, Inc. (Livongo Health)
  • Noom, Inc.
  • Omada Health, Inc.
  • Welldoc, Inc.
  • Canary Health
  • Mango Health, Inc. (TrialCard, Incorporated)
  • 2Morrow, Inc.
  • Pear Therapeutics, Inc.
  • Mindstrong, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Digital Therapeutics Market, by End Use
    • 1.4.2 Global Digital Therapeutics Market, by Application
    • 1.4.3 Global Digital Therapeutics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Restraints:

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Business Expansions
    • 3.2.4 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar - 2021, Mar) Leading Players

Chapter 4. Global Digital Therapeutics Market by End Use

  • 4.1 Global Patients Market by Region
  • 4.2 Global Providers Market by Region
  • 4.3 Global Payers Market by Region
  • 4.4 Global Employers Market by Region
  • 4.5 Global Other End Use Market by Region

Chapter 5. Global Digital Therapeutics Market by Applications

  • 5.1 Global Diabetes Applications Market by Region
  • 5.2 Global CNS Disease Applications Market by Region
  • 5.3 Global Respiratory Diseases Applications Market by Region
  • 5.4 Global Smoking Cessation Applications Market by Region
  • 5.5 Global Obesity Applications Market by Region
  • 5.6 Global CVD Applications Market by Region
  • 5.7 Global Other Applications Market by Region

Chapter 6. Global Digital Therapeutics Market by Region

  • 6.1 North America Digital Therapeutics Market
    • 6.1.1 North America Digital Therapeutics Market by End Use
      • 6.1.1.1 North America Patients Market by Country
      • 6.1.1.2 North America Providers Market by Country
      • 6.1.1.3 North America Payers Market by Country
      • 6.1.1.4 North America Employers Market by Country
      • 6.1.1.5 North America Other End Use Market by Country
    • 6.1.2 North America Digital Therapeutics Market by Applications
      • 6.1.2.1 North America Diabetes Applications Market by Country
      • 6.1.2.2 North America CNS Disease Applications Market by Country
      • 6.1.2.3 North America Respiratory Diseases Applications Market by Country
      • 6.1.2.4 North America Smoking Cessation Applications Market by Country
      • 6.1.2.5 North America Obesity Applications Market by Country
      • 6.1.2.6 North America CVD Applications Market by Country
      • 6.1.2.7 North America Other Applications Market by Country
    • 6.1.3 North America Digital Therapeutics Market by Country
      • 6.1.3.1 US Digital Therapeutics Market
        • 6.1.3.1.1 US Digital Therapeutics Market by End Use
        • 6.1.3.1.2 US Digital Therapeutics Market by Applications
      • 6.1.3.2 Canada Digital Therapeutics Market
        • 6.1.3.2.1 Canada Digital Therapeutics Market by End Use
        • 6.1.3.2.2 Canada Digital Therapeutics Market by Applications
      • 6.1.3.3 Mexico Digital Therapeutics Market
        • 6.1.3.3.1 Mexico Digital Therapeutics Market by End Use
        • 6.1.3.3.2 Mexico Digital Therapeutics Market by Applications
      • 6.1.3.4 Rest of North America Digital Therapeutics Market
        • 6.1.3.4.1 Rest of North America Digital Therapeutics Market by End Use
        • 6.1.3.4.2 Rest of North America Digital Therapeutics Market by Applications
  • 6.2 Europe Digital Therapeutics Market
    • 6.2.1 Europe Digital Therapeutics Market by End Use
      • 6.2.1.1 Europe Patients Market by Country
      • 6.2.1.2 Europe Providers Market by Country
      • 6.2.1.3 Europe Payers Market by Country
      • 6.2.1.4 Europe Employers Market by Country
      • 6.2.1.5 Europe Other End Use Market by Country
    • 6.2.2 Europe Digital Therapeutics Market by Applications
      • 6.2.2.1 Europe Diabetes Applications Market by Country
      • 6.2.2.2 Europe CNS Disease Applications Market by Country
      • 6.2.2.3 Europe Respiratory Diseases Applications Market by Country
      • 6.2.2.4 Europe Smoking Cessation Applications Market by Country
      • 6.2.2.5 Europe Obesity Applications Market by Country
      • 6.2.2.6 Europe CVD Applications Market by Country
      • 6.2.2.7 Europe Other Applications Market by Country
    • 6.2.3 Europe Digital Therapeutics Market by Country
      • 6.2.3.1 Germany Digital Therapeutics Market
        • 6.2.3.1.1 Germany Digital Therapeutics Market by End Use
        • 6.2.3.1.2 Germany Digital Therapeutics Market by Applications
      • 6.2.3.2 UK Digital Therapeutics Market
        • 6.2.3.2.1 UK Digital Therapeutics Market by End Use
        • 6.2.3.2.2 UK Digital Therapeutics Market by Applications
      • 6.2.3.3 France Digital Therapeutics Market
        • 6.2.3.3.1 France Digital Therapeutics Market by End Use
        • 6.2.3.3.2 France Digital Therapeutics Market by Applications
      • 6.2.3.4 Russia Digital Therapeutics Market
        • 6.2.3.4.1 Russia Digital Therapeutics Market by End Use
        • 6.2.3.4.2 Russia Digital Therapeutics Market by Applications
      • 6.2.3.5 Spain Digital Therapeutics Market
        • 6.2.3.5.1 Spain Digital Therapeutics Market by End Use
        • 6.2.3.5.2 Spain Digital Therapeutics Market by Applications
      • 6.2.3.6 Italy Digital Therapeutics Market
        • 6.2.3.6.1 Italy Digital Therapeutics Market by End Use
        • 6.2.3.6.2 Italy Digital Therapeutics Market by Applications
      • 6.2.3.7 Rest of Europe Digital Therapeutics Market
        • 6.2.3.7.1 Rest of Europe Digital Therapeutics Market by End Use
        • 6.2.3.7.2 Rest of Europe Digital Therapeutics Market by Applications
  • 6.3 Asia Pacific Digital Therapeutics Market
    • 6.3.1 Asia Pacific Digital Therapeutics Market by End Use
      • 6.3.1.1 Asia Pacific Patients Market by Country
      • 6.3.1.2 Asia Pacific Providers Market by Country
      • 6.3.1.3 Asia Pacific Payers Market by Country
      • 6.3.1.4 Asia Pacific Employers Market by Country
      • 6.3.1.5 Asia Pacific Other End Use Market by Country
    • 6.3.2 Asia Pacific Digital Therapeutics Market by Applications
      • 6.3.2.1 Asia Pacific Diabetes Applications Market by Country
      • 6.3.2.2 Asia Pacific CNS Disease Applications Market by Country
      • 6.3.2.3 Asia Pacific Respiratory Diseases Applications Market by Country
      • 6.3.2.4 Asia Pacific Smoking Cessation Applications Market by Country
      • 6.3.2.5 Asia Pacific Obesity Applications Market by Country
      • 6.3.2.6 Asia Pacific CVD Applications Market by Country
      • 6.3.2.7 Asia Pacific Other Applications Market by Country
    • 6.3.3 Asia Pacific Digital Therapeutics Market by Country
      • 6.3.3.1 China Digital Therapeutics Market
        • 6.3.3.1.1 China Digital Therapeutics Market by End Use
        • 6.3.3.1.2 China Digital Therapeutics Market by Applications
      • 6.3.3.2 Japan Digital Therapeutics Market
        • 6.3.3.2.1 Japan Digital Therapeutics Market by End Use
        • 6.3.3.2.2 Japan Digital Therapeutics Market by Applications
      • 6.3.3.3 India Digital Therapeutics Market
        • 6.3.3.3.1 India Digital Therapeutics Market by End Use
        • 6.3.3.3.2 India Digital Therapeutics Market by Applications
      • 6.3.3.4 South Korea Digital Therapeutics Market
        • 6.3.3.4.1 South Korea Digital Therapeutics Market by End Use
        • 6.3.3.4.2 South Korea Digital Therapeutics Market by Applications
      • 6.3.3.5 Singapore Digital Therapeutics Market
        • 6.3.3.5.1 Singapore Digital Therapeutics Market by End Use
        • 6.3.3.5.2 Singapore Digital Therapeutics Market by Applications
      • 6.3.3.6 Malaysia Digital Therapeutics Market
        • 6.3.3.6.1 Malaysia Digital Therapeutics Market by End Use
        • 6.3.3.6.2 Malaysia Digital Therapeutics Market by Applications
      • 6.3.3.7 Rest of Asia Pacific Digital Therapeutics Market
        • 6.3.3.7.1 Rest of Asia Pacific Digital Therapeutics Market by End Use
        • 6.3.3.7.2 Rest of Asia Pacific Digital Therapeutics Market by Applications
  • 6.4 LAMEA Digital Therapeutics Market
    • 6.4.1 LAMEA Digital Therapeutics Market by End Use
      • 6.4.1.1 LAMEA Patients Market by Country
      • 6.4.1.2 LAMEA Providers Market by Country
      • 6.4.1.3 LAMEA Payers Market by Country
      • 6.4.1.4 LAMEA Employers Market by Country
      • 6.4.1.5 LAMEA Other End Use Market by Country
    • 6.4.2 LAMEA Digital Therapeutics Market by Applications
      • 6.4.2.1 LAMEA Diabetes Applications Market by Country
      • 6.4.2.2 LAMEA CNS Disease Applications Market by Country
      • 6.4.2.3 LAMEA Respiratory Diseases Applications Market by Country
      • 6.4.2.4 LAMEA Smoking Cessation Applications Market by Country
      • 6.4.2.5 LAMEA Obesity Applications Market by Country
      • 6.4.2.6 LAMEA CVD Applications Market by Country
      • 6.4.2.7 LAMEA Other Applications Market by Country
    • 6.4.3 LAMEA Digital Therapeutics Market by Country
      • 6.4.3.1 Brazil Digital Therapeutics Market
        • 6.4.3.1.1 Brazil Digital Therapeutics Market by End Use
        • 6.4.3.1.2 Brazil Digital Therapeutics Market by Applications
      • 6.4.3.2 Argentina Digital Therapeutics Market
        • 6.4.3.2.1 Argentina Digital Therapeutics Market by End Use
        • 6.4.3.2.2 Argentina Digital Therapeutics Market by Applications
      • 6.4.3.3 UAE Digital Therapeutics Market
        • 6.4.3.3.1 UAE Digital Therapeutics Market by End Use
        • 6.4.3.3.2 UAE Digital Therapeutics Market by Applications
      • 6.4.3.4 Saudi Arabia Digital Therapeutics Market
        • 6.4.3.4.1 Saudi Arabia Digital Therapeutics Market by End Use
        • 6.4.3.4.2 Saudi Arabia Digital Therapeutics Market by Applications
      • 6.4.3.5 South Africa Digital Therapeutics Market
        • 6.4.3.5.1 South Africa Digital Therapeutics Market by End Use
        • 6.4.3.5.2 South Africa Digital Therapeutics Market by Applications
      • 6.4.3.6 Nigeria Digital Therapeutics Market
        • 6.4.3.6.1 Nigeria Digital Therapeutics Market by End Use
        • 6.4.3.6.2 Nigeria Digital Therapeutics Market by Applications
      • 6.4.3.7 Rest of LAMEA Digital Therapeutics Market
        • 6.4.3.7.1 Rest of LAMEA Digital Therapeutics Market by End Use
        • 6.4.3.7.2 Rest of LAMEA Digital Therapeutics Market by Applications

Chapter 7. Company Profiles

  • 7.1 ResMed, Inc. (Propeller Health)
    • 7.1.1 Company Overview
    • 7.1.1 Financial Analysis
    • 7.1.2 Segmental and Regional Analysis
    • 7.1.3 Research & Development Expense
    • 7.1.4 Recent strategies and developments:
      • 7.1.4.1 Approvals and Trials:
      • 7.1.4.2 Partnerships, Collaborations, and Agreements:
  • 7.2 Teladoc Health, Inc. (Livongo Health)
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Recent strategies and developments:
      • 7.2.3.1 Partnerships, Collaborations, and Agreements:
      • 7.2.3.2 Acquisition and Mergers:
  • 7.3 Noom, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Recent strategies and developments:
      • 7.3.2.1 Partnerships, Collaborations, and Agreements:
  • 7.4 Omada Health, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Recent strategies and developments:
      • 7.4.2.1 Partnerships, Collaborations, and Agreements:
      • 7.4.2.2 Acquisition and Mergers:
      • 7.4.2.3 Product Launches and Product Expansions:
  • 7.5 Welldoc, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Recent strategies and developments:
      • 7.5.2.1 Partnerships, Collaborations, and Agreements:
  • 7.6 Canary Health
    • 7.6.1 Company Overview
    • 7.6.2 Recent strategies and developments:
      • 7.6.2.1 Partnerships, Collaborations, and Agreements:
      • 7.6.2.2 Business Expansions:
  • 7.7 Mango Health, Inc. (TrialCard, Incorporated)
    • 7.7.1 Company Overview
    • 7.7.2 Recent strategies and developments:
      • 7.7.2.1 Partnerships, Collaborations, and Agreements:
  • 7.8 2Morrow, Inc.
    • 7.8.1 Company Overview
  • 7.9 Pear Therapeutics, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Partnerships, Collaborations, and Agreements:
      • 7.9.2.2 Acquisition and Mergers:
      • 7.9.2.3 Product Launches and Product Expansions:
  • 7.10. Mindstrong, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Recent strategies and developments:
      • 7.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Global Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 2 Global Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Digital Therapeutics Market
  • TABLE 4 Product Launches And Product Expansions- Digital Therapeutics Market
  • TABLE 5 Business Expansions- Digital Therapeutics Market
  • TABLE 6 Acquisition and Mergers- Digital Therapeutics Market
  • TABLE 7 Global Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 8 Global Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 9 Global Patients Market by Region, 2017 - 2020, USD Million
  • TABLE 10 Global Patients Market by Region, 2021 - 2027, USD Million
  • TABLE 11 Global Providers Market by Region, 2017 - 2020, USD Million
  • TABLE 12 Global Providers Market by Region, 2021 - 2027, USD Million
  • TABLE 13 Global Payers Market by Region, 2017 - 2020, USD Million
  • TABLE 14 Global Payers Market by Region, 2021 - 2027, USD Million
  • TABLE 15 Global Employers Market by Region, 2017 - 2020, USD Million
  • TABLE 16 Global Employers Market by Region, 2021 - 2027, USD Million
  • TABLE 17 Global Other End Use Market by Region, 2017 - 2020, USD Million
  • TABLE 18 Global Other End Use Market by Region, 2021 - 2027, USD Million
  • TABLE 19 Global Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 20 Global Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 21 Global Diabetes Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 22 Global Diabetes Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 23 Global CNS Disease Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 24 Global CNS Disease Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 25 Global Respiratory Diseases Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 26 Global Respiratory Diseases Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 27 Global Smoking Cessation Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 28 Global Smoking Cessation Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 29 Global Obesity Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 30 Global Obesity Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 31 Global CVD Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 32 Global CVD Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 33 Global Other Applications Market by Region, 2017 - 2020, USD Million
  • TABLE 34 Global Other Applications Market by Region, 2021 - 2027, USD Million
  • TABLE 35 Global Digital Therapeutics Market by Region, 2017 - 2020, USD Million
  • TABLE 36 Global Digital Therapeutics Market by Region, 2021 - 2027, USD Million
  • TABLE 37 North America Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 38 North America Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 39 North America Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 40 North America Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 41 North America Patients Market by Country, 2017 - 2020, USD Million
  • TABLE 42 North America Patients Market by Country, 2021 - 2027, USD Million
  • TABLE 43 North America Providers Market by Country, 2017 - 2020, USD Million
  • TABLE 44 North America Providers Market by Country, 2021 - 2027, USD Million
  • TABLE 45 North America Payers Market by Country, 2017 - 2020, USD Million
  • TABLE 46 North America Payers Market by Country, 2021 - 2027, USD Million
  • TABLE 47 North America Employers Market by Country, 2017 - 2020, USD Million
  • TABLE 48 North America Employers Market by Country, 2021 - 2027, USD Million
  • TABLE 49 North America Other End Use Market by Country, 2017 - 2020, USD Million
  • TABLE 50 North America Other End Use Market by Country, 2021 - 2027, USD Million
  • TABLE 51 North America Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 52 North America Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 53 North America Diabetes Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 54 North America Diabetes Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 55 North America CNS Disease Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 56 North America CNS Disease Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 57 North America Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 58 North America Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 59 North America Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 60 North America Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 61 North America Obesity Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 62 North America Obesity Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 63 North America CVD Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 64 North America CVD Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 65 North America Other Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 66 North America Other Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 67 North America Digital Therapeutics Market by Country, 2017 - 2020, USD Million
  • TABLE 68 North America Digital Therapeutics Market by Country, 2021 - 2027, USD Million
  • TABLE 69 US Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 70 US Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 71 US Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 72 US Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 73 US Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 74 US Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 75 Canada Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 76 Canada Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 77 Canada Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 78 Canada Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 79 Canada Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 80 Canada Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 81 Mexico Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 82 Mexico Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 83 Mexico Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 84 Mexico Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 85 Mexico Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 86 Mexico Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 87 Rest of North America Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 88 Rest of North America Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 89 Rest of North America Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 90 Rest of North America Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 91 Rest of North America Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 92 Rest of North America Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 93 Europe Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 94 Europe Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 95 Europe Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 96 Europe Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 97 Europe Patients Market by Country, 2017 - 2020, USD Million
  • TABLE 98 Europe Patients Market by Country, 2021 - 2027, USD Million
  • TABLE 99 Europe Providers Market by Country, 2017 - 2020, USD Million
  • TABLE 100 Europe Providers Market by Country, 2021 - 2027, USD Million
  • TABLE 101 Europe Payers Market by Country, 2017 - 2020, USD Million
  • TABLE 102 Europe Payers Market by Country, 2021 - 2027, USD Million
  • TABLE 103 Europe Employers Market by Country, 2017 - 2020, USD Million
  • TABLE 104 Europe Employers Market by Country, 2021 - 2027, USD Million
  • TABLE 105 Europe Other End Use Market by Country, 2017 - 2020, USD Million
  • TABLE 106 Europe Other End Use Market by Country, 2021 - 2027, USD Million
  • TABLE 107 Europe Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 108 Europe Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 109 Europe Diabetes Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 110 Europe Diabetes Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 111 Europe CNS Disease Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 112 Europe CNS Disease Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 113 Europe Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 114 Europe Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 115 Europe Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 116 Europe Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 117 Europe Obesity Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 118 Europe Obesity Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 119 Europe CVD Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 120 Europe CVD Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 121 Europe Other Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 122 Europe Other Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 123 Europe Digital Therapeutics Market by Country, 2017 - 2020, USD Million
  • TABLE 124 Europe Digital Therapeutics Market by Country, 2021 - 2027, USD Million
  • TABLE 125 Germany Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 126 Germany Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 127 Germany Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 128 Germany Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 129 Germany Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 130 Germany Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 131 UK Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 132 UK Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 133 UK Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 134 UK Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 135 UK Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 136 UK Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 137 France Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 138 France Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 139 France Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 140 France Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 141 France Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 142 France Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 143 Russia Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 144 Russia Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 145 Russia Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 146 Russia Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 147 Russia Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 148 Russia Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 149 Spain Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 150 Spain Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 151 Spain Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 152 Spain Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 153 Spain Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 154 Spain Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 155 Italy Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 156 Italy Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 157 Italy Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 158 Italy Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 159 Italy Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 160 Italy Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 161 Rest of Europe Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 162 Rest of Europe Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 163 Rest of Europe Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 164 Rest of Europe Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 165 Rest of Europe Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 166 Rest of Europe Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 167 Asia Pacific Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 168 Asia Pacific Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 169 Asia Pacific Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 170 Asia Pacific Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 171 Asia Pacific Patients Market by Country, 2017 - 2020, USD Million
  • TABLE 172 Asia Pacific Patients Market by Country, 2021 - 2027, USD Million
  • TABLE 173 Asia Pacific Providers Market by Country, 2017 - 2020, USD Million
  • TABLE 174 Asia Pacific Providers Market by Country, 2021 - 2027, USD Million
  • TABLE 175 Asia Pacific Payers Market by Country, 2017 - 2020, USD Million
  • TABLE 176 Asia Pacific Payers Market by Country, 2021 - 2027, USD Million
  • TABLE 177 Asia Pacific Employers Market by Country, 2017 - 2020, USD Million
  • TABLE 178 Asia Pacific Employers Market by Country, 2021 - 2027, USD Million
  • TABLE 179 Asia Pacific Other End Use Market by Country, 2017 - 2020, USD Million
  • TABLE 180 Asia Pacific Other End Use Market by Country, 2021 - 2027, USD Million
  • TABLE 181 Asia Pacific Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 182 Asia Pacific Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 183 Asia Pacific Diabetes Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 184 Asia Pacific Diabetes Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 185 Asia Pacific CNS Disease Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 186 Asia Pacific CNS Disease Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 187 Asia Pacific Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 188 Asia Pacific Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 189 Asia Pacific Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 190 Asia Pacific Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 191 Asia Pacific Obesity Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 192 Asia Pacific Obesity Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 193 Asia Pacific CVD Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 194 Asia Pacific CVD Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 195 Asia Pacific Other Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 196 Asia Pacific Other Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 197 Asia Pacific Digital Therapeutics Market by Country, 2017 - 2020, USD Million
  • TABLE 198 Asia Pacific Digital Therapeutics Market by Country, 2021 - 2027, USD Million
  • TABLE 199 China Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 200 China Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 201 China Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 202 China Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 203 China Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 204 China Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 205 Japan Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 206 Japan Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 207 Japan Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 208 Japan Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 209 Japan Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 210 Japan Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 211 India Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 212 India Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 213 India Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 214 India Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 215 India Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 216 India Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 217 South Korea Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 218 South Korea Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 219 South Korea Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 220 South Korea Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 221 South Korea Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 222 South Korea Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 223 Singapore Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 224 Singapore Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 225 Singapore Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 226 Singapore Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 227 Singapore Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 228 Singapore Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 229 Malaysia Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 230 Malaysia Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 231 Malaysia Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 232 Malaysia Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 233 Malaysia Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 234 Malaysia Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 235 Rest of Asia Pacific Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 236 Rest of Asia Pacific Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 237 Rest of Asia Pacific Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 238 Rest of Asia Pacific Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 239 Rest of Asia Pacific Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 240 Rest of Asia Pacific Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 241 LAMEA Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 242 LAMEA Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 243 LAMEA Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 244 LAMEA Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 245 LAMEA Patients Market by Country, 2017 - 2020, USD Million
  • TABLE 246 LAMEA Patients Market by Country, 2021 - 2027, USD Million
  • TABLE 247 LAMEA Providers Market by Country, 2017 - 2020, USD Million
  • TABLE 248 LAMEA Providers Market by Country, 2021 - 2027, USD Million
  • TABLE 249 LAMEA Payers Market by Country, 2017 - 2020, USD Million
  • TABLE 250 LAMEA Payers Market by Country, 2021 - 2027, USD Million
  • TABLE 251 LAMEA Employers Market by Country, 2017 - 2020, USD Million
  • TABLE 252 LAMEA Employers Market by Country, 2021 - 2027, USD Million
  • TABLE 253 LAMEA Other End Use Market by Country, 2017 - 2020, USD Million
  • TABLE 254 LAMEA Other End Use Market by Country, 2021 - 2027, USD Million
  • TABLE 255 LAMEA Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 256 LAMEA Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 257 LAMEA Diabetes Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 258 LAMEA Diabetes Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 259 LAMEA CNS Disease Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 260 LAMEA CNS Disease Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 261 LAMEA Respiratory Diseases Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 262 LAMEA Respiratory Diseases Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 263 LAMEA Smoking Cessation Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 264 LAMEA Smoking Cessation Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 265 LAMEA Obesity Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 266 LAMEA Obesity Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 267 LAMEA CVD Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 268 LAMEA CVD Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 269 LAMEA Other Applications Market by Country, 2017 - 2020, USD Million
  • TABLE 270 LAMEA Other Applications Market by Country, 2021 - 2027, USD Million
  • TABLE 271 LAMEA Digital Therapeutics Market by Country, 2017 - 2020, USD Million
  • TABLE 272 LAMEA Digital Therapeutics Market by Country, 2021 - 2027, USD Million
  • TABLE 273 Brazil Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 274 Brazil Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 275 Brazil Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 276 Brazil Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 277 Brazil Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 278 Brazil Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 279 Argentina Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 280 Argentina Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 281 Argentina Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 282 Argentina Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 283 Argentina Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 284 Argentina Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 285 UAE Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 286 UAE Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 287 UAE Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 288 UAE Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 289 UAE Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 290 UAE Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 291 Saudi Arabia Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 292 Saudi Arabia Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 293 Saudi Arabia Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 294 Saudi Arabia Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 295 Saudi Arabia Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 296 Saudi Arabia Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 297 South Africa Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 298 South Africa Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 299 South Africa Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 300 South Africa Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 301 South Africa Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 302 South Africa Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 303 Nigeria Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 304 Nigeria Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 305 Nigeria Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 306 Nigeria Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 307 Nigeria Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 308 Nigeria Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 309 Rest of LAMEA Digital Therapeutics Market, 2017 - 2020, USD Million
  • TABLE 310 Rest of LAMEA Digital Therapeutics Market, 2021 - 2027, USD Million
  • TABLE 311 Rest of LAMEA Digital Therapeutics Market by End Use, 2017 - 2020, USD Million
  • TABLE 312 Rest of LAMEA Digital Therapeutics Market by End Use, 2021 - 2027, USD Million
  • TABLE 313 Rest of LAMEA Digital Therapeutics Market by Applications, 2017 - 2020, USD Million
  • TABLE 314 Rest of LAMEA Digital Therapeutics Market by Applications, 2021 - 2027, USD Million
  • TABLE 315 Key Information - ResMed, Inc.
  • TABLE 316 Key Information - Teladoc Health, Inc.
  • TABLE 317 key information - Noom, Inc.
  • TABLE 318 Key Information - Omada Health, Inc.
  • TABLE 319 key Information - Welldoc, Inc.
  • TABLE 320 Key Information - Canary Health
  • TABLE 321 key information - Mango Health, Inc.
  • TABLE 322 Key Information - 2Morrow, Inc.
  • TABLE 323 Key Information - Pear Therapeutics, Inc.
  • TABLE 324 Key Information - Mindstrong, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar - 2021, Mar) Leading Players
  • FIG 5 Recent strategies and developments: Teladoc Health, Inc.
  • FIG 6 Recent strategies and developments: Omada Health, Inc.
  • FIG 7 Recent strategies and developments: Canary Health
  • FIG 8 Recent strategies and developments: Pear Therapeutics, Inc.